Prostate Cancer Research

Funding research to increase survival and find a cure for men with advanced prostate cancer

News Centre

Posted: 02 April 2021
Tagged: PCR News

Prostate Pod- Matt Ellis

PCR Chairman Matt Ellis outlines why PCR exists, how we navigated the pandemic, and why bringing a large range of different partners together to make progress against prostate cancer is a win-win for everybody.

Listen to the episode here

Throughout the series, we will interviewing different people from the PCR family who play a vital part in our work; from scientists to patients, to fundraisers and medics on the front line fighting this disease.

Mark Clark Appointed as New Chair of Prostate Cancer Research

2 April 2024

Mark Clark Appointed as New Chair of Prostate Cancer Research

Fundraising, PCR News

PCR x DOC Cleaning – London Marathon 2024

28 March 2024

PCR x DOC Cleaning – London Marathon 2024

Fundraising, PCR News

Walk 100 Miles in May for Prostate Cancer Research 2024

27 March 2024

Walk 100 Miles in May for Prostate Cancer Research 2024

Fundraising, PCR News

Jog 31 Miles in March for Prostate Cancer

2 February 2024

Jog 31 Miles in March for Prostate Cancer

Prostate Cancer Research partners with Our Future Health

7 December 2023

Prostate Cancer Research partners with Our Future Health

PCR submits evidence to the Health and Social Care Committee as part of inquiry into men’s health

5 September 2023

PCR submits evidence to the Health and Social Care Committee as part of inquiry into men’s health

All, Fundraising, PCR News

PCR partners with CAC for Prostate Cancer Awareness Month

31 August 2023

PCR partners with CAC for Prostate Cancer Awareness Month

Bayer and Advanced Accelerator Applications (A Novartis Company) sponsor charity Prostate Cancer Research’s new collaborative project supported by IQVIA and backed by over 3,000 patients that aims to unleash the potential of health data

24 August 2023

Bayer and Advanced Accelerator Applications (A Novartis Company) sponsor charity Prostate Cancer Research’s new collaborative project supported by IQVIA and backed by over 3,000 patients that aims to unleash the potential of health data